by John Conrad | Feb 14, 2020 | Member News
Rosalind Franklin University of Medicine and Science announced today a research collaboration with the Chicagoland biotech company Exicure Inc. to develop new therapeutics for genetic diseases. RFU’s Center for Genetic Diseases is working to understand the...
by John Conrad | Feb 12, 2020 | Member News
Technology hub will support 48,000 new economy jobs, with $19 billion economic impact over the next 10 years; University of Illinois Board of Trustees Chairman Edwards and his wife, Anne also give $10 Million to University, half of which will go to IIN and DPI...
by John Conrad | Jan 31, 2020 | Member News
What happens when a highly interdisciplinary and integrated team of scientists, business leaders and students work together across fields of fundamental science, discovery, development, and finance? In the case of Monopar Therapeutics, a Chemistry of Life Processes...
by John Conrad | Jan 27, 2020 | Member News
Download the conference preview and see who you can meet! Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest independent investor conferences focused on established and emerging publicly traded and select private biotech...
by John Conrad | Jan 10, 2020 | Member News
Trammell Crow Company (TCC), one of the largest commercial real estate developers in the United States, is developing Fulton Labs, a best-in-class life sciences laboratory and office building in Chicago’s Fulton Market neighborhood. The new 400,000-square-foot...
by John Conrad | Dec 4, 2019 | Member News
Veteran entrepreneurs and cofounders of Actuate Therapeutics, Inc., Daniel Schmitt and Andrew Mazar, PhD, are taking no chances with their lead clinical candidate 9-ING-41, a promising new treatment for advanced and drug-resistant cancers and select inflammatory...
